Mayo to shut down drug-testing unit
13th Nov 2006, 06:59 GMT
The Mayo Clinic will close the pharmaceutical-testing arm of its Clinical Trial Services unit, citing a limited labor pool and drug-making market in the Midwest.
Mayo to shut down drug-testing unit related news:
- Neurogen commences human testing of obesity drug — Pharmaceutical Business Review Latest News
- Library volunteers just say no to drug testing — LISNews.org
- Evidence For Traumatic Cause Of Carpal Tunnel Syndrome Found By Mayo Clinic Researchers — Health News from Medical News Today
- Mayo researchers offer evidence people with psoriasis greater risk for developing heart disease — EurekAlert! - Breaking News
- Mayo Clinic research reveals 'broken heart syndrome' recurs in 1 of 10 patients — EurekAlert! - Medicine and Health
- New testing version out — DEMOCRACY: INTERNET TV BLOG
- Acquisition expands environmental and EMC testing — Compliance Engineering latest news on Electronicstalk
- Nonminority Medical Students More Satisfied Than Minority Students, Study Finds — Health News from Medical News Today
- Neurogen Announces Phase I Clinical Trial For Proprietary Obesity Drug — Health News from Medical News Today
- SAN FRANCISCO 19, DETROIT 13: Back to earth — Freep.com - RSS
Latest news from bizjournals.com Health Care:Pharmaceuticals headlines:
- United BioSource makes 10th buy, looks for more
- Nonprofits starting to invest in drug companies
- Accentia making changes to its business formula, market focus
- GSK terminates agreement for Genaera frog product
- Gladstone and Merck team to bring drugs to market
- Abbott expects to double vascular business sales
- MIT, Dana-Farber win major cancer grants
- Service Bancorp chair resigns
- Introgen strikes nanotech deal with M.D. Anderson
- Joslin spins out first-ever company, Veraxa Health Inc.